Calidar
Durham, US · Founded 2022 · Delaware corporation
Calidar develops X-ray diffraction imaging technology, including a patented 4D Mammography system that noninvasively maps X-ray scatter signatures in breast tissue to detect molecular-level markers of cancer. The technology aims to provide earlier and more accurate breast cancer diagnosis without biopsies, needles, or contrast injection.
Deep TechHealthtechMedical Devices
Founders & leadership
JC

Joshua CarpenterNamed on SEC filing
SS

Stefan StrykerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$270.8K disclosed across 1 round · 2022
▶$270.8KraisedJan 2022 · 2 investors · Other Health CareRule 506(b)
▶$270.8KraisedJan 2022 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Joshua CarpenterExecutive Officer, Director
- Stefan StrykerExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $270.8K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapDiagonaltx3 shared keywordsDiagonal Therapeutics develops multi-specific clustering antibody therapeutics that bind multiple cell-surface receptors to activate or inhibit dysregulated signaling pathways underlying chronic diseases. Its DIAGONAL Product Engine uses computational and experimental methods to identify clustering antibodies across receptor classes, with a lead candidate (DIAG723) in a Phase 1/2 trial for Hereditary Hemorrhagic Telangiectasia.
CareDx3 shared keywordsCareDx provides molecular diagnostic testing, workflow software, patient support, and pharmacy services for care teams working in transplant, cell therapy, and specialty oncology. Its products support rejection monitoring and complex care management in precision medicine.
Companies competing with Calidar for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Calidar do?
- Calidar develops X-ray diffraction imaging technology, including a patented 4D Mammography system that noninvasively maps X-ray scatter signatures in breast tissue to detect molecular-level markers of cancer. The technology aims to provide earlier and more accurate breast cancer diagnosis without biopsies, needles, or contrast injection.
- How much funding has Calidar raised?
- Calidar has disclosed $270.8K raised across 1 round.
- Where is Calidar headquartered?
- Calidar is headquartered in Durham, US.
